TY - JOUR
T1 - Gut-derived effector T cells circulating in the blood of the rat: Preferential re-distribution by TGFβ-1 and IL-4 maintained proliferation
AU - Bode, Ulrike
AU - Sparmann, Gisela
AU - Westermann, Jürgen
N1 - Copyright:
Copyright 2007 Elsevier B.V., All rights reserved.
PY - 2001
Y1 - 2001
N2 - Effector T cells generated in mesenteric lymph nodes (mLN) preferentially accumulate in mLN and sites drained by them, such as Peyer's patches and the lamina propria of the gut, after circulation in the blood. The molecular mechanisms mediating this re-distribution are poorly understood. To study this, rat T cells from mLN were activated via the T cell receptor and CD28, and injected either intravenously into congenic recipients, or maintained in culture in the presence of various cytokines. Three days later effector T cells were identified in vivo and in vitro, and surface molecule expression and proliferation rate was determined. The data show that in vivo effector mLN T cells express significantly higher levels of activation markers and maintain a higher proliferation rate after entering the mLN environment (tissue of origin) than after entering the peripheral LN environment (unrelated site.) The proliferation is mediated by TGFβ-1 and IL-4 present in mLN. The requirement for these cytokines is imprinted on effector mLN T cells during the initial activation. Thus, the preferential proliferation of effector mLN T cells in milieus providing the cytokine mixture experienced during activation ensures a privileged accumulation at sites where they are most needed. This can be used to manipulate the effector phase of an immune response.
AB - Effector T cells generated in mesenteric lymph nodes (mLN) preferentially accumulate in mLN and sites drained by them, such as Peyer's patches and the lamina propria of the gut, after circulation in the blood. The molecular mechanisms mediating this re-distribution are poorly understood. To study this, rat T cells from mLN were activated via the T cell receptor and CD28, and injected either intravenously into congenic recipients, or maintained in culture in the presence of various cytokines. Three days later effector T cells were identified in vivo and in vitro, and surface molecule expression and proliferation rate was determined. The data show that in vivo effector mLN T cells express significantly higher levels of activation markers and maintain a higher proliferation rate after entering the mLN environment (tissue of origin) than after entering the peripheral LN environment (unrelated site.) The proliferation is mediated by TGFβ-1 and IL-4 present in mLN. The requirement for these cytokines is imprinted on effector mLN T cells during the initial activation. Thus, the preferential proliferation of effector mLN T cells in milieus providing the cytokine mixture experienced during activation ensures a privileged accumulation at sites where they are most needed. This can be used to manipulate the effector phase of an immune response.
UR - http://www.scopus.com/inward/record.url?scp=0034939221&partnerID=8YFLogxK
U2 - 10.1002/1521-4141(200107)31:7<2116::AID-IMMU2116>3.0.CO;2-Q
DO - 10.1002/1521-4141(200107)31:7<2116::AID-IMMU2116>3.0.CO;2-Q
M3 - Journal articles
C2 - 11449365
AN - SCOPUS:0034939221
SN - 0014-2980
VL - 31
SP - 2116
EP - 2125
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 7
ER -